PharmStars is accepting applications for its Spring 2026 cohort: “Digital Innovations in Operations and Outcomes.” Apply by January 25. BOSTON, MA, UNITED STATES, January 6, 2026 /EINPresswire.com/ — ...
14h
Needham Hikes Centessa (CNTA) PT to $38 on High Potential for ORX-750 Trial Success and M&A Appeal
Centessa Pharmaceuticals (NASDAQ:CNTA) is one of the best up and coming stocks to buy according to Wall Street.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback